SCHEMBL9515779

SCHEMBL9515779

CCOc1cccc2c(S(=O)(=O)NC(=O)c3ccc(CO)nc3)cccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.48
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HPGD P15428 3/20 0.43
ALDH1A1 P00352 3/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 2/20 0.40
HTT P42858 1/20 0.40
FABP4 P15090 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517883 0.90 P4HTM (0.47) P4HTMMEN1KMT2AHPGDALDH1A1
SCHEMBL9519579 0.90 P4HTM (0.47) P4HTMMEN1KMT2AHPGDALDH1A1
SCHEMBL9517123 0.88 P4HTM (0.45) P4HTMMEN1KMT2AHPGDALDH1A1
SCHEMBL9517336 0.86 P4HTM (0.44) P4HTMMEN1KMT2AHPGDALDH1A1
SCHEMBL9517081 0.84 FABP4 (0.51) P4HTMMEN1KMT2AALDH1A1NPC1
SCHEMBL9517968 0.82 P4HTM (0.69) P4HTMMEN1KMT2ANPC1RAB9A
SCHEMBL9518028 0.78 FABP4 (0.48) P4HTMMEN1KMT2AHPGDALDH1A1
SCHEMBL9517023 0.77 P4HTM (0.62) P4HTMMEN1KMT2ANPC1RAB9A
SCHEMBL9516931 0.76 FABP4 (0.51) P4HTMALDH1A1L3MBTL1LMNAHTT
SCHEMBL9518008 0.76 P4HTM (0.54) P4HTMKMT2AALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed